About Us
Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions.
Patients treated
Countries worldwide
Published studies
Research projetcs
Regen Lab SA stands as a beacon of innovation in the realm of autologous regenerative medicine. Nestled in the heart of Le Mont-sur-Lausanne, Switzerland, our company specializes in the extemporaneous preparation of Platelet-Rich Plasma (PRP) derived from the patient’s own blood. We also focus on advanced cell therapy techniques, notably the development of combined therapies such as PRP with hyaluronic acid.
In 2009, Regen Lab SA embarked on a significant milestone by inaugurating a state-of-the-art Good Manufacturing Practice (GMP) facility. This advancement has propelled us to the forefront of high-quality medical device production.
Today, our patented technologies are operational in over 160 countries, successfully treating more than 2 million patients across various therapeutic areas including musculoskeletal disorders, dermatology, wound care, and intimate health.
Our commitment to excellence is underscored by our pioneering use of a thixotropic gel for the precise separation of blood components. This innovation ensures that our cell therapy products are both standardized and reproducible. Regen Lab SA is proud to be ISO 13485 certified, with all products conforming to CE standards.
Our Mission
Regen Lab SA is devoted to advancing the frontier of regenerative medicine by delivering state-of-the-art medical devices designed to enhance patient outcomes and elevate quality of life.
Our Facilities
Our GMP-certified facility in Le Mont-sur-Lausanne epitomizes excellence in medical device manufacturing, upholding the highest standards of safety and efficacy.
Global Presence
With a robust presence in over 90 countries, Regen Lab SA is dedicated to expanding its reach, providing innovative regenerative therapies to millions of patients around the globe.
Patents Portfolio
As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community. Innovation represents one of the strongest pillars of the company with more than 50 in-house scientists and a unique network of talented and renowned medical doctors contributing to Regen Lab’s Research & Development.
Active Patents
Regen Lab : A Success Story
Together, let’s make medical innovation a reality for all. It is a vision, a passion, and a commitment to a future where cellular regeneration opens doors to even more promising medical treatments.
Manufacturing sites
Employees
%
Scientists employees
Tubes per year
The Future of Regen Lab: Reaching New Horizons
The story of Regen Lab is far from over. Building on our experience and successes, we continue to explore new ways to improve the health and well-being of patients worldwide. Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.
Global Expansion and International Recognition
Our success knows no borders. Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region. Our strategic partnerships with leading medical institutions and our presence at major global conferences testify to our leadership in the field of regenerative medicine.
3 regional manufacturing footprints for direct access to regulator agencies & close to markets
NEW JERSEY | U.S.A
Since : Q4 2021
Employees : 30
ISO 13485 | MDSAP
LAUSANNE | Switzerland
Since : 2009
Employees : 75
ISO 13485 | MDSAP | EU-MDR 2017/745
PARIS | France
To Start in : 2024
Employees : 40
Certification targeted in Q4 2023
A solid regulatory track record across all major markets and successful operational deployment…
…leading to a global and integrated major player in tissue engineering
Here’s how we have transformed the medical landscape over the past two decades.
Foundation by Antoine Turzi
Founded in 2003 by the visionary Antoine Turzi, Regen Lab SA embarked on its journey with a clear mission: to enhance the quality of life for patients through innovative medical solutions based on cellular regeneration. From the outset, the company focused on developing therapies utilizing the healing properties of platelet-rich plasma (PRP).
ISO 13485
RegenKit first approval in bone graft
A new state-of-theart in Lausanne, Switzerland
With our unwavering commitment to research and development, we have created a range of revolutionary products known for their effectiveness and safety. Today, our PRP therapy solutions are used in over 160 countries by thousands of renowned practitioners.
Cellular Matrix first approval
Regen Lab quickly distinguished itself with its pioneering approach and ability to turn innovative ideas into tangible products. The launch of our patented device for PRP-HA combination preparation marked a decisive mileston.
Launch of Cellular Matrix in Europe
US phase III for Cellular Matrix RegenKit first approval in chronic WoundCare in China
Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region. Our strategic partnerships with leading medical institutions and our presence at major global conferences testify to our leadership in the field of regenerative medicine.
Operational new manufacture in New York State (USA)
USA Granted patents for covering PRP alone medical devices
Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.
RegenKit cleared for WoundCare indication
New subsidiaries in Morocco and Dubai
EU-MDR certification RegenKit & Cellular Matrix
Our products are manufactured to the highest industry standards, and we continually invest in quality audits and international certifications to ensure the safety and efficacy of our solutions.
Inauguration in les Ulis near Paris
Foundation by Antoine Turzi
Founded in 2003 by the visionary Antoine Turzi, Regen Lab SA embarked on its journey with a clear mission: to enhance the quality of life for patients through innovative medical solutions based on cellular regeneration.
RegenKit first approval in bone graft
A new state-of-theart in Lausanne, Switzerland
We have created a range of revolutionary products known for their effectiveness and safety. Today, our PRP therapy solutions are used in over 160 countries by thousands of renowned practitioners.
Cellular Matrix first approval in osteoarthritis and skin care
Launch of Cellular Matrix in Europe
US phase III for Cellular Matrix RegenKit first approval in chronic WoundCare in China
Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region.
Operational new manufacture in New York State (USA)
USA Granted patents for covering PRP alone medical devices
Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.
RegenKit cleared for WoundCare indication
New subsidiaries in Morocco and Dubai
EU-MDR certification RegenKit & Cellular Matrix
Our products are manufactured to the highest industry standards, and we continually invest in quality audits and international certifications to ensure the safety and efficacy of our solutions.